BRIEF published on 11/26/2024 at 00:25, 1 year 2 months ago NexgenRx Reports Q3 Growth and Announces Dividend Financial Results Revenue Increase Dividend Declaration SaaS Solutions EBITDA Growth
BRIEF published on 11/26/2024 at 00:25, 1 year 2 months ago NexgenRx annonce une croissance au troisième trimestre et un dividende Résultats Financiers Solutions SaaS Augmentation Des Revenus Croissance De L'EBITDA Déclaration De Dividendes
PRESS RELEASE published on 11/26/2024 at 00:20, 1 year 2 months ago NexgenRx Announces Third Quarter Results and Declaration of Divdend NexgenRx announces Q3 2024 financial results, with quarterly revenue up to $4,158,667 and increased positive EBITDA of $446,448. A dividend of $0.005 per share declared for shareholders Financial Results Revenue Dividend Q3 2024 NexgenRx
BRIEF published on 10/07/2024 at 23:35, 1 year 4 months ago NexgenRx Re-Appoints Charles Burns to Board of Directors Technology Solutions Board Appointment Canada NexgenRx Charles Burns
BRIEF published on 10/07/2024 at 23:35, 1 year 4 months ago NexgenRx reconduit Charles Burns au sein de son conseil d'administration Canada Nomination Au Conseil D'administration Solutions Technologiques NexgenRx Charles Burns
PRESS RELEASE published on 10/07/2024 at 23:30, 1 year 4 months ago NexgenRx Announces Director Re-Appointment NexgenRx Inc. announces re-appointment of Charles Burns to its Board of Directors. Company provides full-service Third-Party Administrator & Technology Solutions in Canada Board Of Directors Technology Solutions Third-party Administrator NexgenRx Inc. Charles Burns
BRIEF published on 10/01/2024 at 14:05, 1 year 4 months ago NexgenRx Appoints Linda Brennan to Board of Directors Board Of Directors Corporate Governance Appointment NexgenRx Linda Brennan
BRIEF published on 10/01/2024 at 14:05, 1 year 4 months ago NexgenRx nomme Linda Brennan au conseil d'administration Conseil D'administration Gouvernance D'Entreprise Rendez-vous NexgenRx Linda Brennan
PRESS RELEASE published on 10/01/2024 at 14:00, 1 year 4 months ago NexgenRx Announces New Director NexgenRx announces the appointment of Linda Brennan as a new member to its Board of Directors. Linda brings expertise in finance and corporate governance to the company Board Of Directors Appointment Finance NexgenRx Linda Brennan
BRIEF published on 07/18/2024 at 20:05, 1 year 7 months ago NexgenRx Announces Share Issuances Under Consulting Agreement Consulting Agreement Share Issuance NexgenRx PBM Management Services SaaS Model
Published on 02/20/2026 at 20:15, 16 minutes ago Lithium South Announces Results of its Annual and Special Meeting of Securityholders
Published on 02/20/2026 at 20:15, 16 minutes ago Verdera Energy Announces Closing of Qualifying Transaction
Published on 02/20/2026 at 18:30, 2 hours 1 minute ago Sparta Updates Delay in Filing Annual Financial Statements
Published on 02/20/2026 at 15:45, 4 hours 46 minutes ago Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway
Published on 02/20/2026 at 14:30, 6 hours 1 minute ago Norse Gold Announces Application for Reactivation to TSX-V, Private Placement Financing and Stock Options Grant
Published on 02/20/2026 at 18:36, 1 hour 54 minutes ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 1 hour 59 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:00, 2 hours 31 minutes ago Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 2 hours 31 minutes ago Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations
Published on 02/20/2026 at 19:29, 1 hour 1 minute ago SFPI GROUP: bilan du contrat de liquidité S2 S025
Published on 02/20/2026 at 18:00, 2 hours 31 minutes ago TERACT - Résiliation du contrat de liquidité
